Earningsreport

Q1/2023 3/31/2023 EPS -1.810 ZacksConsensus -2.340 ActVsEst 0.530 - Beat

Reata Pharmaceuticals, Inc. - Class A  (RETA) 
Last reata pharmaceuticals, inc. - class a earnings: 2/19 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.reatapharma.com